Medicamen Organics Limited
MEDIORGPharmaceuticals
Incorporated in 1995, Medicamen Organics Limited develops pharmaceutical dosages including generic doses in the form of tablets, capsules, oral liquids, ointments, gels, syrups, suspensions, and dry powders.
122Announcements
02-09-2026Last filed
11Last 90 days
What Medicamen files
- Others49
- Important35
- Board Meeting12
- Updates12
- Investor Meet7
- PPTs2
Showing PPTs announcements (2)Clear filter
04-06-2025 · 11:15 am
Medicamen Organics Limited has informed the Exchange about Investor Presentation
23-11-2024 · 05:08 pm
**H1 FY25 Investor Presentation Summary** **Financial Highlights:** Medicamen Organics reported a total income of ₹1,686 Lakhs in H1 FY25, reflecting a robust 49% year-on-year increase. EBITDA rose 15% to ₹277 Lakhs, while net profit improved by 11% to ₹151 Lakhs. The EBITDA margin decreased from 21% to 16%, and the...